Patent Yard Sign in
Canadian application, no grantCanada

Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension

CA 2428552 A1 · Owner: Block, Lutz-Henning · Inventors: Block, Lutz-Henning

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates to peptides which are highly biologically and pharmacologically active as therapeutic drug for the treatment of diseases related to hypertension, especially in medical interventions involving dilatation and remodelling of arterial blood vessels either in the pulmonary , or in the systemic circulation. The peptides which can be used according to the invention for the treatment of said diseases comprises at least one specific highly conservative amino acid residue sequence which seem to play an important role in connection with pulmonary and arteriolar hypertension events. It could be shown that the known naturally occurring peptides "vasoactive …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 22, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 22, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 22, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 22, 2001
GrantedNo grant recorded
Term endedNovember 22, 2021
Patent numberCA 2428552 A1
Classification (IPC)C07K14/57 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedNov 22, 2001Term endedNov 22, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.